DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,038 filers reported holding DANAHER CORPORATION in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $6,597,380 | +460.2% | 26,405 | +459.9% | 0.01% | +300.0% |
Q1 2024 | $1,177,628 | +144.1% | 4,716 | +126.1% | 0.00% | +100.0% |
Q4 2023 | $482,505 | +127.5% | 2,086 | +144.0% | 0.00% | – |
Q3 2023 | $212,126 | +12.2% | 855 | +8.5% | 0.00% | – |
Q2 2023 | $189,120 | -5.1% | 788 | -0.4% | 0.00% | – |
Q1 2023 | $199,364 | +21.6% | 791 | +27.8% | 0.00% | – |
Q4 2022 | $164,000 | +27.1% | 619 | +23.8% | 0.00% | – |
Q3 2022 | $129,000 | -7.9% | 500 | -9.4% | 0.00% | – |
Q2 2022 | $140,000 | -20.0% | 552 | -7.7% | 0.00% | – |
Q1 2022 | $175,000 | -16.3% | 598 | -5.7% | 0.00% | – |
Q4 2021 | $209,000 | +16.1% | 634 | +7.3% | 0.00% | – |
Q3 2021 | $180,000 | +6.5% | 591 | -6.0% | 0.00% | – |
Q2 2021 | $169,000 | +19.9% | 629 | +0.5% | 0.00% | – |
Q1 2021 | $141,000 | +29.4% | 626 | +28.0% | 0.00% | – |
Q4 2020 | $109,000 | -61.8% | 489 | -82.6% | 0.00% | -100.0% |
Q2 2016 | $285,000 | +4.0% | 2,817 | -2.4% | 0.00% | -50.0% |
Q1 2016 | $274,000 | -7.1% | 2,885 | -9.1% | 0.00% | 0.0% |
Q4 2015 | $295,000 | +21.9% | 3,174 | +11.7% | 0.00% | 0.0% |
Q3 2015 | $242,000 | -1.2% | 2,842 | -0.8% | 0.00% | 0.0% |
Q2 2015 | $245,000 | -21.2% | 2,865 | -21.8% | 0.00% | 0.0% |
Q1 2015 | $311,000 | +14.3% | 3,663 | +15.4% | 0.00% | 0.0% |
Q4 2014 | $272,000 | +8.4% | 3,173 | -3.9% | 0.00% | 0.0% |
Q3 2014 | $251,000 | +1.2% | 3,303 | +5.0% | 0.00% | 0.0% |
Q2 2014 | $248,000 | +306.6% | 3,145 | +256.2% | 0.00% | +100.0% |
Q3 2013 | $61,000 | +8.9% | 883 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $56,000 | – | 883 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |